Follow the Sun Pharma Advanced Research Company Limited stock price and the full management transaction log of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Sun Pharma Advanced Research Company Limited has logged 13 reports. Market capitalisation: €66.9bn. The latest transaction was reported on 23 February 2023 (Pledge). Among the most active insiders: Raksha S Valia. All data is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€69m
3 ops.
Buy Volume
n/a
2 ops.
Sell Volume
14Σ signal
Buys €69mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,856 of 29,064 companies
66.7
score / 100
Value
72
Quality
61
FCF yld-3.9%
Earn yld23%
EV/EBITDA4.5x
ROE277%
Gross mgn-31%
Net mgn·
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.